JP4663985B2 - 味をマスクした獣医用固体組成物 - Google Patents

味をマスクした獣医用固体組成物 Download PDF

Info

Publication number
JP4663985B2
JP4663985B2 JP2003574170A JP2003574170A JP4663985B2 JP 4663985 B2 JP4663985 B2 JP 4663985B2 JP 2003574170 A JP2003574170 A JP 2003574170A JP 2003574170 A JP2003574170 A JP 2003574170A JP 4663985 B2 JP4663985 B2 JP 4663985B2
Authority
JP
Japan
Prior art keywords
particles
benazepril
london
edition
coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2003574170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526756A5 (enExample
JP2005526756A (ja
Inventor
トーマ，ヒユーベルト
シヨーテ，ウーベ・トーマス
イゼーレ，ウーテ
Original Assignee
ノバルティス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27798784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP4663985(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ノバルティス アーゲー filed Critical ノバルティス アーゲー
Publication of JP2005526756A publication Critical patent/JP2005526756A/ja
Publication of JP2005526756A5 publication Critical patent/JP2005526756A5/ja
Application granted granted Critical
Publication of JP4663985B2 publication Critical patent/JP4663985B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
JP2003574170A 2002-03-11 2003-03-10 味をマスクした獣医用固体組成物 Expired - Lifetime JP4663985B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02005511 2002-03-11
EP02005511.7 2002-03-11
PCT/EP2003/002446 WO2003075895A1 (en) 2002-03-11 2003-03-10 Tasted masked veterinary solid compositions

Publications (3)

Publication Number Publication Date
JP2005526756A JP2005526756A (ja) 2005-09-08
JP2005526756A5 JP2005526756A5 (enExample) 2006-04-20
JP4663985B2 true JP4663985B2 (ja) 2011-04-06

Family

ID=27798784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003574170A Expired - Lifetime JP4663985B2 (ja) 2002-03-11 2003-03-10 味をマスクした獣医用固体組成物

Country Status (22)

Country Link
US (2) US20050169971A1 (enExample)
EP (2) EP1803448A3 (enExample)
JP (1) JP4663985B2 (enExample)
KR (1) KR20040101302A (enExample)
CN (1) CN1652754B (enExample)
AR (1) AR038899A1 (enExample)
AT (1) ATE390129T1 (enExample)
AU (1) AU2003218722B2 (enExample)
BR (1) BR0308378B1 (enExample)
CA (1) CA2478811C (enExample)
CO (1) CO5400144A1 (enExample)
DE (1) DE60319969T2 (enExample)
DK (1) DK1490037T3 (enExample)
ES (1) ES2301784T3 (enExample)
MX (1) MXPA04008845A (enExample)
NZ (1) NZ535167A (enExample)
PT (1) PT1490037E (enExample)
RU (1) RU2318498C2 (enExample)
SI (1) SI1490037T1 (enExample)
TW (1) TWI309557B (enExample)
WO (1) WO2003075895A1 (enExample)
ZA (1) ZA200407010B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2556169C (en) * 2004-01-29 2011-11-22 Andrew Lees Use of amino-oxy functional groups in the preparation of vaccines
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
JP2008502727A (ja) * 2004-06-10 2008-01-31 グラット エアー テクニクス インコーポレーテッド 徐放性基材医薬品製剤
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP1935405A1 (en) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Orally disintegrating tablets
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
AU2012307656B2 (en) 2011-09-15 2016-07-07 Friulchem Spa Compositions for oral administration to animals, production methods thereof and uses of same
CZ308210B6 (cs) * 2011-11-02 2020-03-04 Veterinární A Farmaceutická Univerzita Brno Farmaceutická kompozice ve formě pelet majících velikost částic v rozmezí od 0,1 do 10 mm pro perorální podání vodním živočichům a způsob její výroby
RU2014129508A (ru) 2011-12-21 2016-02-10 Новартис Тиргезундхайт АГ Новая комбинация
WO2013135853A1 (en) * 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical packaging product for the veterinary medical sector
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
DK179072B1 (da) * 2012-05-08 2017-10-09 Novartis Tiergesundheit Ag Ny Behandling
FR2991179B1 (fr) 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
WO2014053555A1 (en) 2012-10-04 2014-04-10 Novartis Ag Veterinary drug system
FR3002735B1 (fr) 2013-03-04 2015-07-03 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
FR3002736B1 (fr) 2013-03-04 2015-06-26 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
MX375936B (es) 2013-12-04 2025-03-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmaceuticas mejoradas de pimobendan.
KR101687973B1 (ko) * 2015-12-08 2016-12-21 주식회사 씨티씨바이오 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN105963270B (zh) * 2016-06-30 2019-01-15 齐鲁动物保健品有限公司 一种盐酸贝那普利软咀嚼片及其制备方法
CN109673848A (zh) * 2018-12-29 2019-04-26 广州智特奇生物科技股份有限公司 一种肠溶包被材料、肠道缓释单宁酸及其制备方法
JP7534139B2 (ja) * 2020-07-03 2024-08-14 獣医医療開発株式会社 動物用医薬製剤
CN112220769A (zh) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 一种米尔贝肟吡喹酮风味片及其制备方法
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
CN113768038A (zh) * 2021-09-14 2021-12-10 江苏省协同医药生物工程有限责任公司 一种精准定量实验动物功能性饲料及制备方法与设备
JP7109827B1 (ja) * 2021-11-16 2022-08-01 株式会社ハニック・ホワイトラボ 抗ウイルス剤
CN119033030A (zh) * 2024-09-03 2024-11-29 江西省农业科学院畜牧兽医研究所 一种提高断奶仔猪生产性能的饲料添加剂

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231466A (en) * 1962-10-26 1966-01-25 Walter H Hoffman Composition and method for treating animals and poultry
US3824233A (en) * 1972-07-06 1974-07-16 Lilly Co Eli Anthelmintic phenylhydrazones
US3937825A (en) * 1973-09-21 1976-02-10 American Cyanamid Company Anthelmintic composition and method of use
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
EP0524180B1 (en) 1990-04-11 1995-04-26 The Upjohn Company Taste masking of ibuprofen by fluid bed coating
WO1993024109A1 (en) 1992-06-04 1993-12-09 Smithkline Beecham Corporation Palatable pharmaceutical compositions
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
PT760648E (pt) * 1994-05-20 2002-04-29 Janssen Pharmaceutica Nv Tabletes de flubendazole de mastigacao para animais domesticos
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
JP4195728B2 (ja) * 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ，インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
ES2237121T3 (es) * 1998-07-28 2005-07-16 Takeda Pharmaceutical Company Limited Preparacion solida disgregable rapidamente.
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB2356346A (en) * 1999-11-19 2001-05-23 Mars Uk Ltd Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
BR0207948A (pt) 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
KR20040101302A (ko) 2004-12-02
TW200304774A (en) 2003-10-16
RU2004130433A (ru) 2005-08-10
ZA200407010B (en) 2006-06-28
JP2005526756A (ja) 2005-09-08
CA2478811C (en) 2010-12-14
CN1652754B (zh) 2013-05-22
SI1490037T1 (sl) 2008-08-31
US20050169971A1 (en) 2005-08-04
CA2478811A1 (en) 2003-09-18
CO5400144A1 (es) 2004-05-31
PT1490037E (pt) 2008-05-05
EP1490037A1 (en) 2004-12-29
EP1803448A2 (en) 2007-07-04
EP1803448A3 (en) 2007-09-12
BR0308378B1 (pt) 2013-12-24
DK1490037T3 (da) 2008-07-21
US20100074952A1 (en) 2010-03-25
WO2003075895A1 (en) 2003-09-18
AR038899A1 (es) 2005-02-02
BR0308378A (pt) 2005-01-11
DE60319969D1 (de) 2008-05-08
RU2318498C2 (ru) 2008-03-10
NZ535167A (en) 2006-08-31
EP1490037B1 (en) 2008-03-26
TWI309557B (en) 2009-05-11
ATE390129T1 (de) 2008-04-15
AU2003218722A1 (en) 2003-09-22
US8617587B2 (en) 2013-12-31
ES2301784T3 (es) 2008-07-01
MXPA04008845A (es) 2004-11-26
AU2003218722B2 (en) 2006-08-31
DE60319969T2 (de) 2009-04-30
CN1652754A (zh) 2005-08-10

Similar Documents

Publication Publication Date Title
JP2005526756A (ja) 味をマスクした獣医用固体組成物
US4874613A (en) Taste concealing pharmaceutical dosage unit
US6709678B2 (en) Easy to swallow oral medicament composition
JP5530433B2 (ja) 固体形態の経口投与用の食欲をそそる医薬品
ES2320438T3 (es) Formulacion farmaceutica oral de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio(s) activo(s).
US20110129539A1 (en) Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillin
JP2006502156A (ja) 風味を遮断された投与形態およびそれらの製剤の方法
RS20060238A (sr) Višečestične formulacije pantoprazola
JP2005526756A5 (enExample)
WO2000069420A1 (en) Pulse-delivery oral compositions
JP2006528699A (ja) 抗生物質組成物
US20060159758A1 (en) Coating composition for taste masking coating and methods for their application and use
JP2005521682A (ja) 結腸放出組成物
HUT52369A (en) New form of mediacament
US20070154550A1 (en) Pharmaceutical composition comprising anticonvulsant with taste mask coating
EP1759692A2 (en) Taste-masked solid veterinary compositions
JP2003306428A (ja) 服用性を改善した硬カプセル剤
EP1949900B1 (en) Controlled release solid formulation for oral administration as single dose sachet and method of preparation thereof
JP7534139B2 (ja) 動物用医薬製剤
KR101504199B1 (ko) 위장관 표적 지향형 한방 제제의 제조방법 및 상기 제조방법에 의해 제조된 한방 제제
ZA200407595B (en) Oral suspension of amoxicillin capsules

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060306

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060306

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100316

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100225

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101214

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110106

R150 Certificate of patent or registration of utility model

Ref document number: 4663985

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140114

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term